TSW
PBH icon

Thompson Siegel & Walmsley’s Prestige Consumer Healthcare PBH Stock Holding History

Thompson Siegel & Walmsley’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-30
Closed -$2K – 775
2016
Q2 		$2K Buy
+30
New +$1.65K ﹤0.01% 723

Other funds holding PBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Thompson Siegel & Walmsley's PBH Position: Q3 2016 in Review

Thompson Siegel & Walmsley sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 30 shares — an estimated $2K sold.

Thompson Siegel & Walmsley first reported a position in PBH in Q2 2016 and held it in 1 quarter. The position peaked at $2K in Q2 2016. 245 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

  • Thompson Siegel & Walmsley reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 30 Prestige Consumer Healthcare shares in Q3 2016, an estimated $2K.
  • Thompson Siegel & Walmsley first reported a position in Prestige Consumer Healthcare in Q2 2016 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's Prestige Consumer Healthcare position peaked at $2K in Q2 2016.
  • 245 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2016, filed 14 Nov 2016.